Identification of a novel peptide ligand of human vascular endothelia growth factor receptor 3 for targeted tumour diagnosis and therapy

Journal of Biochemistry

Volumn 142, Issue 1, 2007, Pages 79-85

  Qin, Xin ^a,b   Wan, Yi ^a,b   Li, Meng ^a,b   Xue, Xiaochang ^a,b   Wu, Shouzhen ^a,b   Zhang, Cun ^a,b   You, Yanjie ^a,b   Wang, Weihua ^a,b   Jiang, Changli ^a,b   Liu, Yan ^a,b   Zhu, Wenhua ^a,b   Ran, Yonggang ^a,b   Zhang, Zhen ^a,b   Han, Wei ^a,b   Zhang, Yingqi ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b State Key Laboratory of Cancer Biology   (China)

Author keywords

Peptide; Phage display; VEGFR 3

Indexed keywords

AMINO ACID; VASCULOTROPIN RECEPTOR 3; CYSTEINYL SERYL ASPARTYL SERYL TRYPTOPHYL HISTIDYL TYROSYL TRYPTOPHYL CYSTEINE; CYSTEINYL-SERYL-ASPARTYL-SERYL-TRYPTOPHYL-HISTIDYL-TYROSYL-TRYPTOPHYL-CYSTEINE; FLUORESCEIN ISOTHIOCYANATE; LIGAND; OLIGOPEPTIDE; PEPTIDE; PEPTIDE LIBRARY; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CANCER CELL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIGAND BINDING; PHAGE DISPLAY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN TARGETING; SYNTHESIS; AMINO ACID SEQUENCE; BINDING SITE; CHEMISTRY; ENDOTHELIUM CELL; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MOLECULAR GENETICS; NEOPLASM; PROTEIN DATABASE; TUMOR CELL LINE;

AMINO ACID SEQUENCE; BINDING SITES; CELL LINE, TUMOR; DATABASES, PROTEIN; ENDOTHELIAL CELLS; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; NEOPLASMS; OLIGOPEPTIDES; PEPTIDE LIBRARY; PEPTIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 38449105127     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvm109     Document Type: Article

References (23)

1. Reubi, J.C. (2003) Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev. 24, 389-427
2. Wagner, H.N. Jr. (1996) Nuclear medicine: 100 years in the making. J. Nucl. Med. 37, 18N,24N, 37N
3. Valtola, R., Salven, P., Heikkila, P., Taipale, J., Joensuu, H., Rehn, M., Pihlajaniemi, T., Weich, H., deWaal, R., and Alitalo, K. (1999) VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am. J. Pathol. 154, 1381-1390
4. Stacker, S.A., Baldwin, M.E., and Achen, M.G. (2002) The role of tumor lymphangiogenesis in metastatic spread. FASEB 16, 922-934
5. Williams, C.S., Leek, R.D., Robson, A.M., Banerji, S., Prevo, R., Harris, A.L., and Jackson, D.G. (2003) Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J. Pathol. 200, 195-206
6. Saaristo, A., Partanen, T.A., Arola, J., Jussila, L., Hytönen, M., Mäkitie, A., Vento, S., Kaipainen, A., Malmberg, H., and Alitalo, K. (2000) Vascular Endothelial Growth Factor-C and its receptor VEGFR-3 in the nasal mucosa and in nasopharyngeal tumors. Am. J. Pathol. 157, 7-14
7. Yu, X.M., Lo, C.Y., Chan, W.F., Lam, K.Y., Leung, P., and Luk, J.M. (2005) Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases. Clin. Cancer Res. 11, 8063-8069
8. Branca, M., Giorgi, C., Santini, D., Bonito, L.D., Ciotti, M., Benedetto, A., Paba, P., Costa, S., Bonifacio, D., Bonito, P.Di., Accardi, L., and Favalli, C. (2006) Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J. Clin. Pathol. 59, 40-47
9. Ueda, M., Hung, Y.C., Terai, Y., Kanda, K., Kanemura, M., Futakuchi, H., Yamaguchi, H., Akise, D., Yasuda, M., and Ueki, M. (2005) Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas. Clin. Cancer Res. 11, 3225-3232
10. Lu, Z.Q., Li, H.G., Xie, D.R., Zhang, H.Z., Sheng, X.M., Zeng, J.Y., and Zeng, H. (2005) Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma. Chinese J. Cancer 24, 1132-1135
11. Zeng, Y.P., Opeskin, K., Baldwin, M.E., Horvath, L.G., Achen, M.G., Stacker, S.A., Sutherland, R.L., and Williams, E.D. (2004) Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin. Cancer Res. 10, 5137-5144
12. Kubo, H., Fujiwara, T., Jussila, L., Hashi, H., Ogawa, M., Shimizu, K., Awane, M., Sakai, Y., Takabayashi, A., Alitalo, K., Yamaoka, Y., and Nishikawa, S.I. (2000) Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 96, 546-553
13. Pytowski, B. (2005) Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J. Natl Cancer Inst. 97, 14-21
14. He, Y., Rajantie, I., Pajusola, K., Jeltsch, M., and Alitalo, K. (2005) Vasular endothelial cell growth factor receptor 3 mediated activation of lymphatic endothelium is crucial for tumor cell entry and spead via lymphatic vessels. Cancer Res. 65, 4739-4746
15. Qian, Z.M., Li, H., and Sun, H. (2002) Targted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Res. 54, 561-587
16. Wu, P., Leinonen, J., Koivunen, E., Lankinen, H., and Stenman, U.H. (2000) Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity. Eur. J. Biochem. 267, 6212-6220
17. Meng, J.R, Ma, N., Yan, Z., Han, W., and Zhang, Y.Q. (2006) NGR enhanced the anti-angiogenic activity of tum-5. J. Biochem. 140, 1-6
18. Sacchi, A., Gasparri, A., Curnis, F., Bellone, M., and Corti, A. (2004) Crucial role for interferon γ in the synergism between tumor vasculature-targeted tumor necrosis factor α (NGR-TNF) and doxorubicin. Cancer Res. 64, 7150-7155
19. Mayada, E-M., Lioudmila, T., Ludmila, Y., Pietrzynski, G., Moreno, M., Stanimirovic, D., Ahmad, D., and Alakhov, V. (2003) A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library. J. Biol. Chem. 278, 46681-46691
20. Rubio, D.A., Marty, C., Console, S., Zeisberger, S.M., Ruch, C., Jaussi, R., Schwendener, R.A., and Ballmer-Hofer, K. (2005) Targeting human cancer cells with VEGF receptor-2-directed liposomes. Oncol. Rep. 13, 319-324
21. Garces, C.A., Kurenova, E.V., Golubovskaya, V.M., and Cance, W.G. (2006) Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. Cancer Res. 66, 1446-1454
22. Troiani, T., Lockerbie, O., Morrow, M., Ciardiello, F., and Eckhardt, S.G. (2006) ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases, blocks VEGF-C-induced activation of VEGFR-3 and cell proliferation in human colon cancer cell lines. J Clin Oncol. 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 13171
23. Pajusola, K., Aprelikova, O., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R., and Alitalo, K. (1992) Flt4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res. 52, 5738-5743